Drug Type Small molecule drug |
Synonyms CI 959 |
Target- |
Action inhibitors |
Mechanism Histamine release inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC14H15N5NaO3S |
InChIKeyWEPDZDGEBWNUPX-UHFFFAOYSA-N |
CAS Registry104795-68-8 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Asthma | Phase 2 | United States | - | - |
| Asthma | Phase 2 | - | - | |
| Myocardial Ischemia | Phase 1 | United States | - | - |
| Myocardial Ischemia | Phase 1 | - | - | |
| Rhinitis, Allergic | Phase 1 | United States | - | - |
| Rhinitis, Allergic | Phase 1 | - | - | |
| Colitis, Ulcerative | Preclinical | United States | - | - |
| Crohn Disease | Preclinical | United States | - | - |
| Neoplasms | Preclinical | Switzerland | - | - |
| Peptic Ulcer | Preclinical | United States | - | - |





